- Quality of life - Health - Food
Institute of Plant Sciences Paris-Saclay (IPS2)
Research unit
The Institute of Plants Sciences Paris-Saclay has a role to better understand the genetic and molecular mechanisms that control the growth of the plant and its regulation by the endogenous and exogenous signals of biotic origin (bacteria and fungi) and abiotic (environmental, nutrients or other). This research combines genomics, molecular and cellular biology, bioinformatics, biochemistry and physiology. The institute has 3 platforms: translational biology, transcriptomic and metabolomic biology, which allows it to position itself on various innovative projects in partnership with the industrial partners to contribute to the agriculture of tomorrow.
Innovation themes
Rue de Noetzlin
Bâtiment 630, Plateau du Moulon, CS 80004
91192 GIF-SUR-YVETTE
Expertises
- endogenous and exogenous signals of biotic origin (bacteria and fungi) and abiotic (environmental stress, nutrients, etc.)
Applications sectors
- Agri-food industry
- Agriculture
- Cosmetics
Total number of employees
Number of researchers : 53
Number of doctoral students : 26
Equipment(s) open to collaboration
- metabolomic platform
- transcriptomic platform
- translational platform
- culture chamber
- epifluorescence microscope
- confocal microscope
Keywords
Projects examples
- RNA regulation in root development
- analysis of transcription factors between cell proliferation and differentiation under normal and stress conditions
- projet ERC Advanced Grant: genes characterization of Sexual melon determinism (2 articles on nature)...
- projet SAMUTAGENE
Industrial and scientific relations
Scientific collaborations
- France: Pierre Bourgin Institute, CEA Cadarache
- Europe: University of Nottingham UK, many ANR,
- International: Nobel Foundation (USA), ARRIAM St Petersburg (Russia),
CRAG (Spain), JIC (UK), MPI (Germany), University of Tasmania (Australia), Benchbio (India)
Private collaborations
- 1 project with Bayer, Syngenta, Mondelez
- small companies BIOtransfer, BIOPHYTECH, COVERTIS, undergoing creation of start-up